Valet P, Montastruc J L, Berlan M, Tran M A, Lafontan M, Montastruc P
Institut National de la Santé et de la Recherche Médicale Unité 317, Toulouse, France.
J Pharmacol Exp Ther. 1989 Apr;249(1):271-7.
The effects of long-term endogenous catecholamine exposure on the regulation of leukocyte and adipocyte beta adrenoceptor subtypes were studied through an experimental model of chronic neurogenic hypertension in the dog. Chronic sinoaortic denervation (SAD) is associated with a significant increase in plasma catecholamine levels, a reduction in the total beta adrenoceptor number of the leukocytes (52%) as well as of the omental adipocytes (59%). Using highly selective beta antagonists (bisoprolol for beta-1; ICI 118,551 for beta-2 adrenoceptors) we demonstrate that the normal dog fat cell possess both beta-2 and beta-1 adrenoceptors in proportions of 67 and 33%, respectively. SAD-induced catecholamine enhancement promotes a strong reduction of beta-2 (but not beta-1) adrenoceptor number (from 237 +/- 28 to 52 +/- 13 fmol/mg of protein) leading to a new relative distribution in fat cell membranes: 36% for beta-2 and 64% for beta-1 adrenoceptors. Such a different regulation provokes major consequences in the associated-biological effect on adipocytes when evaluating the lipolytic process. Lipolysis induced by epinephrine or isoproterenol (two mixed agonists) is weakly but significantly reduced whereas lipolysis induced by procaterol (a highly selective beta-2 agonist) is strongly reduced. These data fit with the results of the binding studies and demonstrate the loss in beta-2 adrenoceptor number and efficiency in SAD dogs. The present study demonstrates a differential regulation of beta adrenoceptors: beta-2 but not beta-1 adrenoceptors are decreased by long-term exposure to high plasma levels of endogenous catecholamines in the dog.
通过犬慢性神经源性高血压实验模型,研究了长期内源性儿茶酚胺暴露对白细胞和脂肪细胞β肾上腺素能受体亚型调节的影响。慢性窦主动脉去神经支配(SAD)与血浆儿茶酚胺水平显著升高、白细胞(52%)和网膜脂肪细胞(59%)的总β肾上腺素能受体数量减少有关。使用高选择性β拮抗剂(比索洛尔用于β-1;ICI 118,551用于β-2肾上腺素能受体),我们证明正常犬脂肪细胞同时拥有β-2和β-1肾上腺素能受体,比例分别为67%和33%。SAD诱导的儿茶酚胺增强促进β-2(而非β-1)肾上腺素能受体数量的强烈减少(从237±28降至52±13 fmol/mg蛋白质),导致脂肪细胞膜上新的相对分布:β-2为36%,β-1为64%。在评估脂解过程时,这种不同的调节在对脂肪细胞的相关生物学效应中引发了重大后果。肾上腺素或异丙肾上腺素(两种混合激动剂)诱导的脂解作用轻微但显著降低,而丙卡特罗(一种高选择性β-2激动剂)诱导的脂解作用则强烈降低。这些数据与结合研究结果相符,证明了SAD犬中β-2肾上腺素能受体数量和效率的丧失。本研究证明了β肾上腺素能受体的差异调节:长期暴露于犬体内高血浆水平的内源性儿茶酚胺会使β-2而非β-1肾上腺素能受体减少。